GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.64 $2.31 Friday, 19th Apr 2024 CTMX stock ended at $1.67. This is 3.47% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 6.73% from a day low at $1.64 to a day high of $1.75.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2020-10-26 $6.58 $6.85 $6.50 $6.65 251 843
2020-10-23 $6.78 $6.85 $6.67 $6.76 730 416
2020-10-22 $6.57 $6.77 $6.43 $6.75 474 105
2020-10-21 $6.69 $6.80 $6.54 $6.57 261 020
2020-10-20 $6.71 $6.81 $6.51 $6.71 668 822
2020-10-19 $6.95 $7.06 $6.68 $6.69 517 256
2020-10-16 $6.85 $7.00 $6.82 $6.86 212 996
2020-10-15 $6.64 $6.82 $6.56 $6.81 356 568
2020-10-14 $6.94 $7.21 $6.70 $6.77 372 364
2020-10-13 $6.86 $6.95 $6.78 $6.90 272 435
2020-10-12 $6.83 $6.94 $6.74 $6.85 253 180
2020-10-09 $6.94 $6.99 $6.76 $6.82 180 242
2020-10-08 $7.01 $7.08 $6.87 $6.90 241 635
2020-10-07 $6.73 $7.01 $6.71 $6.94 259 135
2020-10-06 $7.07 $7.07 $6.69 $6.70 300 840
2020-10-05 $6.59 $7.06 $6.50 $7.02 325 523
2020-10-02 $6.76 $6.84 $6.40 $6.47 553 359
2020-10-01 $6.68 $6.93 $6.68 $6.91 272 458
2020-09-30 $6.70 $6.83 $6.59 $6.65 345 495
2020-09-29 $6.69 $6.80 $6.63 $6.69 186 535
2020-09-28 $6.82 $6.84 $6.63 $6.69 188 722
2020-09-25 $6.56 $6.88 $6.50 $6.80 506 699
2020-09-24 $6.57 $6.75 $6.38 $6.56 483 827
2020-09-23 $6.78 $6.97 $6.58 $6.61 364 222
2020-09-22 $6.65 $6.84 $6.41 $6.72 551 561
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT